Skip to main content

Table 3 New diagnoses in this cohort

From: Increased diagnostic yield by reanalysis of data from a hearing loss gene panel

Patient ID

Gene

Reference

Allele 1*

Allele 2

Inheritance

Time to diagnosis

Family history

Date of report

Reason to upgrade

Reference; Published date

1

MYO15A

NM_016239.3

c.10245_10247delCTC; p.Ser3417del

c.9314_9315insC; p.His3106Profs*2

AR

3 y

No

September 2016

New publication

PMID29482514; February 2018

2

MYO15A

NM_016239.3

c.10245_10247delCTC; p.Ser3417del

c.10245_10247delCTC; p.Ser3417del

AR

27 y

YES

March 2017

New publication

PMID29482514; February 2018

3

MYO7A

NM_000260.3

c.3671C > A; p. Ala1224Asp

c.397dupC; p. His133Profs*7

AR

4 y

YES

July 2015

New publication

PMID26968074; April 2016

4

MITF

NM_198159.2

c.1021C > G; p.Arg341Gly

N/A

AD

29 y

No

August 2016

New publication

PMID29484430; January 2018 and PMID30394532; November 2018

5

MITF

NM_198159.2

c.1021C > T; p.Arg341Cys

N/A

AD

5 y

No

December 2014

New publication

PMID27057829; April 2016

6

TMC1

NM_138691.2

c.1250G > A; p. Gly417Glu

c.1250G > A; p.Gly417Glu

AR

48 y

YES

November 2015

ACMG/AMP Guidelines (PM5)

PMID25741868; May 2015

7

CDH23

NM_022124.5

c.1037C > G; p. Pro346Arg

c.489delA; p. Gly165Alafs*25

AR

21 y

YES

July 2015

ACMG/AMP Guidelines (PM5)

PMID25741868; May 2015

8

PAX3

NM_001127366.2

c.870_871insC; p. Gly292Argfs*118

N/A

AD

26 y

No

January 2017

Expanded analysis

N/A

9

TMC1

NM_138691.2

EX6_EX10, DEL

c.1333C > T

AR

8 y

No

December 2014

Expanded analysis

N/A

  1. *Variants of allele 1 were those upgraded from variants of uncertain significance to likely pathogenic. PM5 denotes a pathogenic moderate criterion from the variant interpretation guidelines recommended by the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. AR autosomal recessive. AD autosomal dominant. N/A Not applicable